Cited by 1,219SARS-CoV-2 and COVID-19 ResearchEnzyme Structure and FunctionAnimal Virus Infections Studies

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Open access
Yin, Wanchao, Mao, Chunyou, Luan, Xiaodong, Shen, Dan-Dan, Shen, Qingya, Su, Haixia, Wang, Xiaoxi, Zhou, Fulai +14 more·2020·Science

Published version of a preprint

Abstract

A wrench in the works of COVID-19: Understanding the inner workings of the virus that causes coronavirus disease 2019 (COVID-19) may help us to disrupt it. Yin et al. focused on the viral polymerase essential for replicating viral RNA. They determined a structure of the polymerase bound to RNA and to the drug remdesivir. Remdesivir mimics an RNA nucleotide building block and is covalently linked to the replicating RNA, which blocks further synthesis of RNA. The structure provides a template for designing improved therapeutics against the viral polymerase. Science , this issue p. 1499

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abc1560

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SARS-CoV-2 catalytic virulence factors, such as its two proteases, Mpro and PLpro, and the RNA-dependent RNA polymerase (Rdrp), are potentially targetable by a PROTAC.

    “but SARS-CoV-2 catalytic virulence factors, such as its two proteases, Mpro and PLpro201, and the RNA-dependent RNA polymerase (Rdrp), which is the target of remdesivir202, are potentially targetable by a PROTAC.”

    From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [202]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., Chang, S., Xie, Y.-C., Tian, G., Jiang, H.-W., Tao, S.-C., Shen, J., Jiang, Y., Jiang, H., Xu, Y., Zhang, S., Zhang, Y., & Xu, H. E.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Sir Run Run Shaw Hospital (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Department of Biophysics, and Department of Pathology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Biortus (China) (CN)
  • The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Xu, Yechun
  • Zhang, Shuyang
  • Zhang, Yan
  • Xu, H. Eric
Venue
Science
Published
2020-06-26
Volume
368
Issue
6498
Pages
1499-1504
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3022734398
Cited by
1,219
References
51
Citations by year
2026: 54 · 2025: 80 · 2024: 91 · 2023: 154 · 2022: 214 · 2021: 352 · 2020: 274
FWCI
32.76
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Science (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (31770796)
  • National Key Research and Development Program of China Stem Cell and Translational Research (2016YFA050230)
  • National Science Foundation of China (81922071)
  • National Science and Technology Major Project (2018ZX09711002)
  • Shanghai Municipal Science and Technology Major Project (2019SHZDZX02)
  • Jack Ma Foundation (2020-CMKYGG-05)
  • CAMS Innovation Fund for "13th Five-Year" National Science and Technology Major Project (2019ZX09734001-002)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords
SARS-CoV-2, RNA-dependent RNA polymerase, remdesivir, antiviral drug mechanism, viral RNA replication, chain termination, cryo-EM structure, drug design
MeSH terms
Betacoronavirus, SARS-CoV-2, Coronavirus RNA-Dependent RNA Polymerase, Adenosine Monophosphate, Alanine, Antiviral Agents, Enzyme Inhibitors, Models, Molecular, Protein Conformation, RNA-Dependent RNA Polymerase, RNA, Viral, Virus Replication, Viral Nonstructural Proteins, Catalytic Domain, Cryoelectron Microscopy, Multiprotein Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review